Clinical trials
Idiopathic Pulmonary Fibrosis trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
| Completed | 9 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Hoffmann-La Roche | 3 |
| Actelion | 2 |
| Boehringer Ingelheim | 2 |
| Gilead Sciences | 2 |
| Rabin Medical Center | 2 |
| United Therapeutics | 2 |
| AstraZeneca | 1 |
| Biogen | 1 |
| Bridge Biotherapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 29 |
| Lung Diseases, Interstitial | 7 |
| Pulmonary Fibrosis | 5 |
| Connective Tissue Diseases | 1 |
| Fibrosis | 1 |
| Idiopathic Interstitial Pneumonias | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.